id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0319-0003,FDA,FDA-2005-P-0319,FDA/CDER Interim Response to Luitpold Pharmaceuticals Inc,Other,LET-Letter,2005-09-07T04:00:00Z,2005,9,,,2010-05-14T21:07:52Z,,0,0,0900006480447e12
FDA-2005-P-0319-0001,FDA,FDA-2005-P-0319,See FDA-2005-P-0319-0002,Supporting & Related Material,BKG-Background Material,2005-03-07T05:00:00Z,2005,3,,,2010-05-14T21:10:44Z,,0,0,0900006480447df8
FDA-2005-P-0319-0002,FDA,FDA-2005-P-0319,"Acknowledgement Letter to Luitpold Pharmaceuticals, Inc., (Sonnenschein Nath & Rosenthal LLP)",Other,ACK-Acknowledgement Letter,2005-03-07T05:00:00Z,2005,3,,,2010-05-14T21:06:03Z,,0,0,0900006480447e0e